Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes

CMAJ. 2013 Aug 6;185(11):963-7. doi: 10.1503/cmaj.120112. Epub 2013 Jun 3.

Authors

Doreen M Rabi¹, Raj Padwal, Sheldon W Tobe, Richard E Gilbert, Lawrence A Leiter, Robert R Quinn, Nadia Khan; Canadian Hypertensive Education Program; Canadian Diabetes Association

Affiliation

¹ Department of Medicine, University of Calgary, Calgary, Alta. doreen.rabi@albertahealthservices.ca

No abstract available

Publication types

Review

MeSH terms

Aged
Antihypertensive Agents / administration & dosage*
Comorbidity
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / epidemiology*
Dose-Response Relationship, Drug
Drug Administration Schedule
Evidence-Based Medicine
Female
Humans
Hypertension / diagnosis
Hypertension / drug therapy*
Hypertension / epidemiology*
Male
Middle Aged
Prognosis
Risk Assessment
Treatment Outcome

Substances

Antihypertensive Agents